top signin

Pin It

interior-banner-mask

.

Press 2017

Dec 22, 2017

Biostage Announces Reverse Stock Split Effective December 22, 2017...

- Required for financing agreement - - Reverse split ratio of 1-for-20 -     HOLLISTON, Mass., Dec. 22, 2017 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG), ("Biostage" or the "Company"), a...


Dec 14, 2017

Biostage Announces Binding Agreement For $4.0 Million Private Placement...

- Investment will provide a path forward for Biostage - - Focus remains on continued development in Pediatric Esophageal Atresia and Adult Esophagus - - Closing and funding are expected to occur...


Oct 12, 2017

Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives...

- Emphasizes Robustness of its Technology Despite Financial Uncertainty - - Responds to Termination Letter from First Pecos, LLC -   HOLLISTON, Mass., Oct. 12, 2017 /PRNewswire/ -- Biostage, Inc. (OTC-QB:...


Oct 06, 2017

Biostage to Move to OTCQB Marketplace...

- Delisted from NASDAQ effective October 6, 2017 - - Delivers notice of breach to First Pecos, LLC -   HOLLISTON, Mass., Oct. 6, 2017 /PRNewswire/ -- Biostage, Inc. ("Biostage" or the "Company"), a...


Oct 02, 2017

Biostage to Present at the 2017 Cell & Gene Meeting on the Mesa...

- Presentation with live video webcast Thursday, October 5th at 4:45 PM PDT -   HOLLISTON, Mass., Oct. 2, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a...


Aug 14, 2017

Biostage Reports 2017 Second Quarter Financial Results:...

Closes $3M private placement Secures guarantee to fund company through 2018 with future rights offerings - Investor Chip Greenblatt and Dr. Saverio La Francesca appointed to Biostage Board of...


Aug 07, 2017

Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Pati...

- Procedure approved via the FDA's single-use expanded access program and was performed at a major U.S. hospital -   HOLLISTON, Mass., Aug. 7, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG),...


Aug 04, 2017

Biostage to Host Conference Call to Discuss Second Quarter 2017 Financial Result...

- Conference Call with Live Audio Webcast on Monday, August 14th at 9:00 AM ET -   HOLLISTON, Mass., Aug. 4, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a...


Jul 10, 2017

Biostage Granted Continued Listing on Nasdaq...

HOLLISTON, Mass., July 10, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Jun 27, 2017

Biostage Announces Agreement to Conduct $3.1 Million Private Placement at Market...

- Strategic investor provides opportunity through future rights offering for additional gross proceeds up to $14 million - - Total proceeds will enable the Company to advance first-in-human clinical study...


Jun 19, 2017

Biostage Announces Positive Preclinical Data of Cellspan™ Esophageal Implant P...

HOLLISTON, Mass., June 19, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Jun 14, 2017

Biostage to Present at the 2017 Marcum MicroCap Conference...

HOLLISTON, Mass., June 14, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


May 23, 2017

Biostage to Present at the Cell and Gene Exchange 2017...

- Presentation with live video webcast today, May 23rd at 11:15 AM ET -   HOLLISTON, Mass., May 23, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a...


May 22, 2017

Biostage Announces Receipt of Nasdaq Listing Determination...

- Company to request hearing -   HOLLISTON, Mass., May 22, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ...


May 11, 2017

Biostage Reports 2017 First Quarter Financial Results and Provides Business Upda...

- First quarter marked by operational improvements, clinical readiness and greater scientific validation - Company remains on track to file IND with FDA for esophageal implant program in Q3 2017 -...


May 09, 2017

Dr. Christine Finck of Connecticut Children's Medical Center, Presents Data in P...

- Dr. Finck's Presentation Awarded Best Poster in Basic Science at APSA - With the support of Dr. Joseph Vacanti, Biostage's Scientific Advisory Board Co-Chairman, and Dr. Christine Finck, pediatric...


May 05, 2017

Biostage to Host 2017 First Quarter Update Conference Call...

HOLLISTON, Mass., May 5, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


May 01, 2017

Biostage to Present at the American Association for Thoracic Surgery Centennial ...

HOLLISTON, Mass., May 1, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Apr 26, 2017

Biostage to Participate at the Alliance for Regenerative Medicine's 5th Annual C...

HOLLISTON, Mass., April 26, 2017 /PRNewswire/ -- Biostage Inc., (Nasdaq: BSTG), ("Biostage" or the "Company), a biotechnology company developing bioengineered organ implants to treat cancers and other...


Apr 18, 2017

Biostage Appoints Stephen F. Badylak DVM, PhD, MD, as Co-Chairman of Scientific ...

HOLLISTON, Mass., April 18, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Apr 06, 2017

Biostage Presents Positive Preclincal Data of Cellspan Esophageal Implant at Soc...

  HOLLISTON, Mass., April 6, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat...


Mar 28, 2017

Biostage to Participate at the MassBio 2017 Annual Meeting...

  HOLLISTON, Mass., March 28, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Mar 16, 2017

Biostage Promotes Saverio La Francesca, M.D. to President...

- Dr. La Francesca responsible for leading scientific and clinical advancement of Company's lead program, Cellspan esophageal implants, into human clinical trials before the end of 2017   HOLLISTON,...


Mar 09, 2017

Biostage Reports 2016 Financial Results and Provides Business Update...

- 2016 marked by establishing a strong foundation on operational, clinical and regulatory fronts in anticipation of a transformational year ahead - Growing body of proof-of-concept preclinical data from...


Mar 02, 2017

Biostage to Host Fiscal Year 2016 Update Conference Call...

HOLLISTON, Mass., March 2, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Feb 16, 2017

Biostage Announces Closing of $8.0 Million Public Offering...

HOLLISTON, Mass., Feb. 16, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Feb 10, 2017

Biostage Announces $8.0 Million Public Offering...

HOLLISTON, Mass., Feb. 10, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and...


Jan 06, 2017

Biostage to Present at Biotech Showcase™ 2017...

- Presentation with Live Webcast on Monday, January 9th at 2:30 p.m. PT -   HOLLISTON, Mass., Jan. 6, 2017 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a...